Interactions of Probiotics with the Immune Cells of Patients with COVID-19 Pneumonia
Journal of Innate Immunity · 2025
DOI: 10.1159/000545873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, 2025. Verfasst von Ioannis Mitrou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece. Hauptthemen laut MEDLINE: Probiotics, COVID-19, SARS-CoV-2, Leukocytes, Mononuclear. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
In severe COVID-19, excessive cytokine release may be driven by SARS-CoV-2. We investigated the modulatory effect of probiotics taking into consideration direct interaction with the immune gut cells.
Methods
Fifty-five patients with confirmed COVID-19 infection were classified by the presence of acute respiratory distress syndrome (ARDS) or not. Peripheral blood mononuclear cells (PBMCs) were isolated and stimulated with lipopolysaccharide (LPS), a preparation of four probiotics (LactoLevure® containing Saccharomyces boulardii, Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5, and L. plantarum) and/or recombinant human interferon-gamma (rhIFNγ) and tocilizumab. Cytokine concentrations were measured in cell supernatants. Gene expression of Toll-like receptors 2 (TLR2) and 4 (TLR4) was performed by quantitative real-time polymerase chain reaction (RT-PCR). Results were associated with the level of viremia.
Results
Probiotics decreased tumor necrosis factor-alpha (TNFα) production by the PBMCs of both ARDS and non-ARDS patients. LPS stimulated the production of interleukin (IL)-1β, IL-6 in non-ARDS patients. IL-6 production was maintained in the presence of probiotics. rhIFNγ enhanced LPS-stimulated cytokine production by PBMCs; this was not the case when PBMCs were stimulated by probiotics. Probiotics upregulated TLR2 and LPS downregulated TLR4 in the PBMCs of patients with ARDS. PBMCs from patients with viremia had more cytokine production by probiotic stimulation.
Conclusion
Probiotics interact with the immune system of COVID-19 patients by modulating the production of TNFα, IL-1β, and IL-6 in an IFNγ-independent mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fourth Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece.
- Third Department of Critical Care Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece.
- Hellenic Institute for the Study of Sepsis, Athens, Greece.
Zitieren
APA
Mitrou, I., Dimopoulos, G., Dakou, K., Koufargyris, P., Damoraki, G., Gkavogianni, T., & Giamarellos-Bourboulis, E. J. (2025). Interactions of Probiotics with the Immune Cells of Patients with COVID-19 Pneumonia. Journal of Innate Immunity. https://doi.org/10.1159/000545873
Vancouver
Mitrou I, Dimopoulos G, Dakou K, Koufargyris P, Damoraki G, Gkavogianni T, et al. Interactions of Probiotics with the Immune Cells of Patients with COVID-19 Pneumonia. Journal of Innate Immunity. 2025. doi:10.1159/000545873
BibTeX
@article{Mitrou2025,
author = {Mitrou, Ioannis and Dimopoulos, George and Dakou, Konstantina and Koufargyris, Panagiotis and Damoraki, Georgia and Gkavogianni, Theologia and Giamarellos-Bourboulis, Evangelos J},
title = {Interactions of Probiotics with the Immune Cells of Patients with COVID-19 Pneumonia},
journal = {Journal of Innate Immunity},
year = {2025},
doi = {10.1159/000545873}
}
EUVIMED